Dr. Afshin A. Nahavandi, MD

Dr. Nahavandi practices at Aurora Behavioral Healthcare San Diego Hospital in San Diego, California, part of Signature HealthCARE.

Dr. Nahavandi's NPI, 1518935808, was assigned on March 10, 2006. Dr. Nahavandi graduated from Tehran University of Medical Sciences School of Medicine in 1994. Dr. Nahavandi's California license number on file is A86078.

Dr. Nahavandi's primary practice is Aurora Behavioral Healthcare San Diego Hospital, at 11878 Avenue of Industry, San Diego, CA 92128 in San Diego County. The practice phone is (858) 487-3200.

Dr. Nahavandi's primary practice is Aurora Behavioral Healthcare San Diego Hospital in San Diego, California, part of Signature HealthCARE. Dr. Nahavandi is also affiliated with Palomar Medical Center Downtown Escondido. The medical group on file is Vituity. Dmand AI also links Dr. Nahavandi to 1 more hospital, 8 medical groups, 4 skilled nursing facilities, 3 hospices and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nahavandi practices, 11 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Nahavandi's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Nahavandi is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Nahavandi's licenses on file in 2 states: California and Ohio.

Dmand AI lists acute diabetes, acute stomach ulcer, anemia, cardiac arrhythmia, cellulitis, circulation problems, circulatory problems in extremities and collapsed lung among the conditions Dr. Nahavandi treats.

CMS data shows 3,276 Medicare services from Dr. Nahavandi across 10 procedure codes in 2024, for 1,091 Medicare patients. Medicare paid $287,570 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,091 Medicare patients who saw Dr. Nahavandi in 2024. The largest group is 75 to 84, with 393 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nahavandi's median patient age at 63, with 50% women.

In 2024, Dr. Nahavandi wrote 2,431 Medicare Part D claims for 332 patients. 84% of them were for generic drugs. CMS names the drug for 1,858 of them, across 64 drugs with 11 or more claims each, at $86,169 in total drug cost. In 2023, CMS named 1,567 claims across 55 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Nahavandi for performance year 2024, reported as part of a group. Dr. Nahavandi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Nahavandi.

CMS Open Payments shows 6 general payments to Dr. Nahavandi from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $177.

Dr. Nahavandi graduated from Tehran University of Medical Sciences School of Medicine in 1994.

Dr. Nahavandi is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.